These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19797538

  • 1. Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.
    Italia KY, Jijina FF, Chandrakala S, Nadkarni AH, Sawant P, Ghosh K, Colah RB.
    J Clin Pharmacol; 2010 Feb; 50(2):231-4. PubMed ID: 19797538
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia.
    Ballas SK, McCarthy WF, Guo N, DeCastro L, Bellevue R, Barton BA, Waclawiw MA, Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    J Natl Med Assoc; 2009 Oct; 101(10):1046-51. PubMed ID: 19860305
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic modulation of fetal hemoglobin.
    Steinberg MH, Rodgers GP.
    Medicine (Baltimore); 2001 Sep; 80(5):328-44. PubMed ID: 11552087
    [No Abstract] [Full Text] [Related]

  • 6. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Oct; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Virtual consult--pregnant woman with sickle-cell disease.
    Borhan S.
    Medscape Womens Health; 1999 Oct; 4(1):6. PubMed ID: 10089559
    [Abstract] [Full Text] [Related]

  • 11. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [Abstract] [Full Text] [Related]

  • 12. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R, Hsieh MM, Zhao X, Calvaruso G, Rigano P, Renda D, Tisdale JF, Maggio A.
    Int J Mol Sci; 2018 Feb 28; 19(3):. PubMed ID: 29495591
    [Abstract] [Full Text] [Related]

  • 13. The role of hydroxyurea in sickle cell disease.
    Halsey C, Roberts IA.
    Br J Haematol; 2003 Jan 28; 120(2):177-86. PubMed ID: 12542474
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study.
    Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR.
    J Pediatr; 2002 Feb 28; 140(2):225-9. PubMed ID: 11865275
    [Abstract] [Full Text] [Related]

  • 16. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
    Powars DR.
    J Pediatr; 2001 Dec 28; 139(6):763-4. PubMed ID: 11743496
    [No Abstract] [Full Text] [Related]

  • 17. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
    Lemonne N, Charlot K, Waltz X, Ballas SK, Lamarre Y, Lee K, Hierso R, Connes C, Etienne-Julan M, Romana M, Connes P.
    Haematologica; 2015 Oct 28; 100(10):e383-6. PubMed ID: 26137960
    [No Abstract] [Full Text] [Related]

  • 18. [Study of hemoglobinopathies found in Belgium].
    Fondu P.
    Bull Mem Acad R Med Belg; 1995 Oct 28; 150(10-11):367-75; discussion 376-8. PubMed ID: 8845787
    [Abstract] [Full Text] [Related]

  • 19. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Oct 28; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 20. Update on the use of hydroxyurea therapy in sickle cell disease.
    Wong TE, Brandow AM, Lim W, Lottenberg R.
    Blood; 2014 Dec 18; 124(26):3850-7; quiz 4004. PubMed ID: 25287707
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.